Image courtesy of SMMA

BioMed Realty has completed its acquisition of a South End office building and life science development site for $314 million, with the Boston Planning & Development Agency scheduled to vote Thursday on the lab conversion.

The transaction includes the 242,000-square-foot office building at 1000 Washington St. as well as a 235,000-square-foot office building under construction next-door at 321 Harrison Ave.

Banker & Tradesman was the first to report in January that BioMed was in discussions with developers Nordblom Co. and CIM Group to acquire the properties for an office-to-lab conversion.

The lab conversion hit a roadblock in April when the BPDA board of directors tabled a vote after two members and a pair of city councilors criticized developers for insufficient neighborhood outreach.

BPDA board member Ted Landsmark said the agency should require developers to reach out to non-English speaking populations and community groups. The BPDA’s review of the Suffolk Downs redevelopment in East Boston was delayed last year following a lawsuit by the Lawyers for Civil Rights objecting to insufficient translation services for community meetings and project documents.

BPDA directors are scheduled to take up the lab conversion approval again at Thursday’s monthly meeting.